OWP
PACB icon

ORG Wealth Partners’s Pacific Biosciences PACB Stock Holding History

ORG Wealth Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$128 – 641
2025
Q3 		$128 Hold
100
– – ﹤0.01% 612
2025
Q2 		$129 Hold
100
– – ﹤0.01% 651
2025
Q1 		$113 Buy
+100
New +$153 ﹤0.01% 740

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ORG Wealth Partners's PACB Position: Q4 2025 in Review

ORG Wealth Partners sold out of Pacific Biosciences (PACB) in Q4 2025, closing a stake of 100 shares — an estimated $128 sold.

ORG Wealth Partners first reported a position in PACB in Q1 2025 and held it in 3 quarters. The position peaked at $129 in Q2 2025. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

  • ORG Wealth Partners reported no remaining Pacific Biosciences position as of Q4 2025 after selling out during the quarter.
  • ORG Wealth Partners sold 100 Pacific Biosciences shares in Q4 2025, an estimated $128.
  • ORG Wealth Partners first reported a position in Pacific Biosciences in Q1 2025 and held it in 3 quarters.
  • ORG Wealth Partners's Pacific Biosciences position peaked at $129 in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on ORG Wealth Partners's 13F filing for Q4 2025, filed 14 Jan 2026.